Form 4 for GILD Gilead Sciences

Accepted 2026-09-02 16:12:46 ET · period of report 2026-09-01 · accession 0001638643-26-000031 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MT	2026-09-02 16:12	2026-09-01	GILD	O'Day Daniel Patrick	COB, CEO, Dir	S - Sale	$148.64	-15.0K	577.1K	-3%	-$2.23M

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2026-09-01	S	D	1,600	$147.51	590,533	D	—	—	(F1) The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026. (F2) Sale prices for the transactions reported range from $146.94 to $147.92. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
2	Common	Common Stock	2026-09-01	S	D	7,992	$148.36	582,541	D	—	—	(F1) The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026. (F3) Sale prices for the transactions reported range from $147.95 to $148.93. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
3	Common	Common Stock	2026-09-01	S	D	5,408	$149.38	577,133	D	—	—	(F1) The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026. (F4) Sale prices for the transactions reported range from $148.96 to $149.94. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.